News

Check out our latest news and events below.

Access Accelerated: A New Way Forward in Global Health

By Dave Ricks

Medical science in recent decades has made extraordinary progress in the fight against many diseases. Unfortunately, far too many people do not benefit from all of this progress, especially those living in some low- and middle-income communities.  The World Health Organization reports that 400 million people worldwide do not have access to essential health services.[i]  Access Accelerated–a new multi-stakeholder partnership announced this week—aims to confront that dismal statistic.
Involving the World Bank, the Union for International Cancer Control and several pharmaceutical companies, Access Accelerated seeks to improve care for noncommunicable diseases (NCDs) by overcoming barriers to health-care access.  Eli Lilly and Company, which I lead, is proud to be a part of this global collaboration. watch full Bastille Day 2016 film online

NCDs—such as cancer, chronic respiratory disease, diabetes, heart disease, and mental illness—are responsible for three out of five deaths across the world. Their impact is especially high in many low- and middle-income countries, where limited resources and longstanding barriers impede access to care. Access Accelerated will pilot new approaches to prevent, diagnose, and treat NCDs in hard-hit areas and will draw on solutions developed by individual companies’ global health programs—including Lilly’s.

For two decades, the Lilly Global Health Partnership has connected people in resource-limited communities with much-needed care. We began by working with Drs. Paul Farmer and Jim Kim to address the spread of multidrug-resistant tuberculosis (MDR-TB) in Peru, but seeing the full complexity of unmet needs, we were determined to do more. So Lilly undertook a decade-long technology-transfer effort to make MDR-TB treatments more accessible by having them manufactured closer to where they were needed. Later, we created community-based projects to improve the delivery of care in four MDR-TB “hotspots.” Along the way, we and our partners learned a great deal about improving access in sustainable ways. These lessons helped us when we expanded our global health efforts to include NCDs, namely, diabetes and cancer in eight countries. 

Improving access to health care means working across geographies with many different players who often face similar issues. To facilitate learning across all of the groups involved, we employ an evidence-based approach and design projects with built-in metrics to show which interventions work and which do not. This “Research, Report, Advocate” approach involves researching new community-based interventions, widely reporting findings to benefit other governments with similar challenges, and advocating for adoption of proven solutions. This approach leads to better informed government health decision making to promote better health for millions of people in other countries.

We recently announced a new company-wide commitment—known as Lilly 30×30. With Lilly 30×30, we are going beyond our existing global-health partnership and mobilizing teams across the company to help create sustainable access for people we do not reach today. By 2030, we aim to reach 30 million people in resource-limited settings each year—a six-fold increase over our current reach—by developing new solutions to the unique challenges facing people in resource-limited settings. In other words, the ingenuity that Lilly employees bring to discovering medicines for cancer, diabetes, and other diseases every day will also be leveraged to get those medicines to more people who need them.

Access Accelerated is a welcome catalyst to share what Lilly learns even more broadly and to integrate the best practices of others into our own work. Together, in the coming years, I’m convinced that we can close the gap in health-care access and bring medical progress to millions more people.

Ricks is President and Chief Executive Officer of Eli Lilly and Company.


[i]
http://www.who.int/mediacentre/news/releases/2015/uhc-report/en/

 

TERMS OF USE

IFPMA (“we”, “us”) owns and operates www.ifpma.org (“the/our website”). Any person accessing and/or using the website (“the visitor/user”) agrees to the “Terms of Use”, containing the conditions, rules and other provisions with respect to the access and/or use of our website. If you have questions about the “Terms of Use”, please feel free to contact us at admin@ifpma.org.

CONTENT

General Use

The material contained on this website is for information only. The website is entitled to be served as an information resource for the internal and external stakeholders of IFPMA, including the general public. Third-Party Websites Links to other websites are provided solely as a convenience and therefore imply neither IFPMA’s responsibility for, nor its approval of the information contained in these websites. Intellectual Property Any use of information from the website should have an acknowledgement of IFPMA/Third-Party as a source respectively, citing the corresponding uniform resource locator (URL). Logo and Name The use of IFPMA’s name and/or logo is prohibited without prior express authorization from IFPMA. The access and/or use of the website does not permit to copy, reproduce, modify, distribute or elsehow exploit IFPMA’s name and/or logo except with the prior explicit permission. Abuse and Violation Any abuse or violations of the Terms of Use and/or Privacy Policy should be reported to admin@ifpma.org.

DISCLAIMER

IFPMA renounces any liability or responsibility for any damages of any nature whatsoever resulting from the use of, inability to use, and/or reliance on the material and information contained on our website. IFPMA makes no representations or warranties as to the completeness or accuracy of any of the information available on the website as well as does not provide any warranties regarding the security of the content of our website or any linked websites. IFPMA endeavours to make its best effort to keep the information accurate and updated on a regular basis, however this is not claimed to be exhaustive. IFPMA does not guarantee that the website is continuously available and error-free at all times.

Privacy Policy

IFPMA is committed to protecting the privacy and security of visitors to our website. Outlined below is our online privacy policy for information collected through our website. If you have questions about these policies, please feel free to contact us at admin@ifpma.org.

Personal Information

We constantly analyse our website logs to improve the value of our website. We do not use this analysis to record or track any personally identifiable information of our visitors. If you are asked to provide personal information such as your name, e-mail or/and postal address when requesting information, providing feedback, registering to a newsletter, or using any other functions of the website, be assured that all such information is considered by IFPMA both private and secure. IFPMA does not share or sell your personal information to third parties. Under no circumstance will details be disclosed publicly, except in order to comply with any legal obligation. This policy reiterates that IFPMA fully appreciates the importance of online privacy and is committed to protecting your personal information.

Use of Cookies Files

Our website is enhanced by cookie files to personalize and customize the experience of our visitors and to support some necessary functions. IFPMA collects broad usage statistics using Google Analytics, to better understand how our visitors use our website, and to help us improve visitors’ experience. Such information includes the IP address (where available), browser type, and any additional information provided by a browser during the use of our website. The statistical data about our users’ browsing actions and patterns does not identify any individual. You may choose to accept or refuse cookies by modifying your browser preferences. If you wish to get notified when a cookies are set, this option should also be available in your browser settings. Please note that if you reject some or all cookies, your experience at this and other websites throughout the Internet may not be complete.

Payment Transactions

To enable IFPMA to process any order or registration to an event, a secure online payment system may be used to process payments using credit card details. IFPMA will not be collecting or storing credit card details in our system.

Third-Party Websites

Please be aware that other websites to which links may be provided, including social media, may collect visitor’s personally identifiable information when accessed. The information collection practices of other websites linked to IFPMA’s website are not covered by this Privacy Policy.